Lisata Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Lisata Therapeutics

09/05/2023 23:06

* Lisata Therapeutics Inc  LSTA.OQ  reported a quarterly
adjusted
loss of 77 cents​​ per share for the quarter ended in March. The
mean expectation of two analysts for the quarter was for a loss
of 81 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Lisata Therapeutics Inc's reported EPS for the quarter was
a
loss of 77 cents​.
    * The mean earnings estimate of analysts had risen by
about 19% in
the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Lisata Therapeutics Inc shares had risen by 0.8% this
quarter and gained 29.2% so far this year.
    * The company reported a quarterly loss of $6.19 million.
    * Wall Street's median 12-month price target for Lisata
Therapeutics Inc is $15.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
9 at 10:06 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.81          -0.77          Beat
 Dec. 31 2022      -1.01          -0.76          Beat
 Sep. 30 2022      -0.90          -7.88          Missed
 Jun. 30 2022      -1.45          -1.65          Missed